Atul Pathak
PCRonline Editorial Board Advisor
Declaration of interest
| Function | Company |
|---|---|
| Honorarium | Ablative Solution |
| Honorarium | CVRx |
| Honorarium | Medtronic |
| Honorarium | Recor Medical |
Latest contributions
Novelties and future developments of sympathetic denervation to control blood pressure
21 May 2025 – From EuroPCR 2025
Discover the latest novelties and future directions in sympathetic denervation for blood pressure control. This session presents preclinical safety data, lesion characteristics, anatomic guidance innovations, multi-organ denervation pilot studies, and breakthrough technologies like the Electroducer sleeve to enhance renal denervation interventions.
The future of renal denervation in Europe: A five-year perspective
04 Nov 2024
This article assesses the future of RDN in Europe, considering recent technological, clinical, and regulatory developments.
Author
Author
Get ready – how to set up a successful renal denervation programme
18 May 2023 – From EuroPCR 2023
Delve into the essentials of renal denervation. Explore current evidence, program setup strategies, and building a multidisciplinary hypertension team.
REVIVED: will this trial change my practice?
17 May 2023 – From EuroPCR 2023
Within this collection of slides, acquire insights into the efficient management of patients with ischaemic heart disease and the identification of those who may benefit from revascularisation. Delve into a thorough review of the REVIVED trial, encompassing its methods, results, and conclusions.
Innovations in device-based treatment for hypertension
17 May 2023 – From EuroPCR 2023
Join this session to explore the latest innovations in device-based treatment for hypertension. Gain a comprehensive understanding of the evidence supporting the efficacy, durability, and safety of radiofrequency renal denervation, learn from renowned experts about the renal denervation procedure and receive valuable insights on patient selection...
From proof to practice - Treating hypertension with ultrasound renal denervation
16 May 2023 – From EuroPCR 2023
Renal denervation: what are the latest clinical evidences and benefits? How to select the good candidate? How to establish a dedicated centre? All the anwers to these questions and more in this video.
Comeback of renal denervation: The ESC Council on hypertension/EAPCI clinical consensus statement
16 May 2023 – From EuroPCR 2023
Ready to rejuvenate your memory of this session tackling on renal denervation? Investigate these slides and review the take home messages.
Renal denervation for treatment of hypertension – heading for new shore
19 Jul 2022
View this replay of a LIVE Round Table Webinar - Renal denervation for treatment of hypertension - with F. Mahfoud, A. Pathak, K. Tsioufis and T. Zellera
EuroPCR 2022 Hotlines / Late-Breaking Trials in hypertension management: SPYRAL-HTN ON MED, radiance HTN SOLO and TRIO, and more!
17 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in hypertension management! Blood pressure and MACE reductions after renal denervation: 3-year GSR results, patient-level pooled analysis of ultrasound RDN in radiance-HTN SOLO and Trio, and SPYRAL-HTN ON MED 3 year data.
RADIANCE-HTN TRIO: what does this mean for the treatment of hypertension?
18 May 2021 – From EuroPCR 2021
Watch this session presented by Atul Pathak in order to learn about the recent clinical advancements in the renal denervation procedure with the Paradise Ultrasound RDN system, and to hear the expert's perspective on the recently announced results from RADIANCE-HTN TRIO (blinded, sham-controlled, powered to demonstrate BP lowering...
What every interventional cardiologist should know about new cardiovascular drugs
Hannah McConkey (UK) talks to cardiologist and pharmacologist Atul Pathak (France) about the important changes in recent drug therapy. They discuss the easy-to-use lipid-lowering PCSK9 inhibitors, and ask should cardiologists now be prescribing the new classes of antidiabetic drugs? The key messages in antithrombotic therapy, and how to...
Interventions for hypertension beyond the renal artery: a case-based discussion
23 May 2019 – From EuroPCR 2019
Consult this session to learn more about non-renal interventions for hypertension and the different device features, procedural steps and patient selection.
What's new in hypertension treatment – An update for interventionists
23 May 2019 – From EuroPCR 2019
Consult this session to discover the updates in hypertension treatment: learn about new devices for hypertension management, how to apply the new hypertension guidelines in clinical practice, and more!
What every interventional cardiologist should know about new cardiovascular drugs
23 May 2019 – From EuroPCR 2019
Consult this session to learn all about the impact of new cardiovascular drugs in patients with coronary artery disease, diabetes and other high-risk conditions, such as PCSK9 and SGLT-2 inhibitors, GLP1 agonists, and more!
Renal interventions for hypertension
22 May 2019 – From EuroPCR 2019
Consult this session to discover renal interventions for hypertension, with compelling cases such as renal artery denervation in presence of renal artery stenosis, intravascular echo-guided percutaneous revascularisation of a renal artery occlusion in pediatric resistant nefrovascular hypertension, and more!
What every interventional cardiologist should know about new cardiovascular drugs
22 May 2019 – From EuroPCR 2019
Consult this session to learn all about the major impact of several new cardiovascular drugs in patients with coronary artery disease, diabetes and other high-risk conditions, such as PCSK9, DAPT, and more!
